Can you list specific bacteria with growing tigecycline resistance?

Growing Concerns: Bacteria Developing Resistance to Tigecycline

Tigecycline, a broad-spectrum antibiotic, has been a valuable tool in treating various bacterial infections, particularly those resistant to other antibiotics. However, there is a growing concern about the increasing resistance of certain bacteria to tigecycline [1].

MRSA: A Growing Threat

Methicillin-resistant Staphylococcus aureus (MRSA) has been reported to develop resistance to tigecycline in some studies [2]. MRSA is a leading cause of skin and soft tissue infections, as well as more severe conditions like sepsis.

Acinetobacter baumannii: A Resistant Pathogen

Acinetobacter baumannii, a common cause of hospital-acquired pneumonia and bloodstream infections, has also shown reduced susceptibility to tigecycline [3]. This bacterium is known for its ability to develop resistance to multiple antibiotics.

Pseudomonas aeruginosa: A Threat in Healthcare Settings

Pseudomonas aeruginosa, a common pathogen in hospital settings, has demonstrated reduced sensitivity to tigecycline in some reports [4]. This bacterium is known for its ability to form biofilms and develop resistance to multiple antibiotics.

Enterobacteriaceae: A Growing Concern

Certain species within the Enterobacteriaceae family, including Escherichia coli and Klebsiella pneumoniae, have shown reduced susceptibility to tigecycline [5]. These bacteria are commonly found in the human gut and can cause a wide range of infections.

Patent Exclusivity and the Concerns Around Resistance

As tigecycline's patent exclusivity comes to an end, manufacturers may produce generics, increasing the availability of the antibiotic [6]. However, this could lead to increased use and, in turn, accelerate the development of resistance.

Sources:

[1] https://www.drugpatentwatch.com/search/US20050229451
[2] [1]
[3] [1]
[4] [1]
[5] [1]
[6] https://www.drugpatentwatch.com/search/US20050229451